Cancer doctors say drugs system is unfit for purpose

[:content [\2 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \  \S \e \n \i \o \r \space \d \o \c \t \o \r \s \space \i \n \v \o \l \v \e \d \space \i \n \space \t \h \e \space \t \r \e \a \t \m \e \n \t \space \o \f \space \c \a \n \c \e \r \space \p \a \t \i \e \n \t \s \space \h \a \v \e \space \s \a \i \d \space \m \a \n \y \space \o \f \space \t \h \e \m \space \a \r \e \space \n \o \t \space \g \e \t \t \i \n \g " ..."]]
Read more →

Companies at SMC meetings

In October 2013, the Scottish Government published its response to the Health and Sport Committee inquiry into access to new medicines. This recommended ...

Read more →

Process changes for end of life and very rare conditions

[:content [\6 \space \M \a \y \space \2 \0 \1 \4 \space \- \  " ..."]]
Read more →

SMC advice - March 2014

[:content [\1 \3 \space \M \a \r \c \h \  \2 \0 \1 \4 \space \- \  \T \h \e \space \S \M \C \space \a \d \v \i \c \e \space \f \o \r \space \M \a \r \c \h \space \2 \0 \1 \4 \space \h \a \s \space \b \e \e \n \space \e \n \t \e \r \e \d \space \i \n \t \o \space \M \A \E \S \T \r \O \space \S \c \o \t \l \a \n \d \. " ..."]]
Read more →

ABPI comments on Scottish New Medicines Fund

[:content (" ...")]
Read more →

Price cut call as cancer drug rejected for routine NHS use

Drug manufacturers have been accused of demanding too much money for life-extending medication after a second cutting-edge breast cancer treatment within ...

Read more →

June 2015 decisions news release

The Scottish Medicines Consortium (SMC) has today published advice accepting four new medicines for use in NHS Scotland. ...

Read more →

SMC rejects Novartis' full submission for everolimus (Afinitor) for women with breast cancer

Everolimus (Afinitor) is not recommended for use within NHS Scotland for the treatment of hormone receptor-positive, human epidermal growth factor type
...
Read more →

Scottish patients get access to Roche's CLL drug on NHS

From today patients in Scotland with chronic lymphocytic leukaemia (CLL) have gained ‘routine’ access to a new treatment option after ...

Read more →

New NHS drugs ‘to create £50m black hole’

[:content [\2 \6 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \  \A \n \space \o \v \e \r \h \a \u \l \space \i \n \space \t \h \e \space \w \a \y \space \l \i \f \e \s \a \v \i \n \g \space \d \r \u \g \s \space \a \r \e \space \a \p \p \r \o \v \e \d \space \f \o \r \space \u \s \e \space \i \n \space \S \c \o \t \l \a \n \d \space \c \o \u \l \d \space \l \e \a \v \e \space \a \space \Â \£ \5 \0 " ..."]]
Read more →

SMC - forthcoming submissions

Below a list of forthcoming submissions that have recently been added to the SMC's programme. Information in relation to the drug ...

Read more →

Fury over cancer setback: Scots denied wonder drug that extends life up to five years

A drug used to treat women with the form of cancer that led Angelina Jolie to have her ovaries removed has been ...

Read more →

SMC - Forthcoming submissions

Below a list of forthcoming submissions that have recently been added to the SMC's work programme. ...

Read more →

SMC no for Zytiga but four new meds are in

The Institute of Cancer Research is calling on the Scottish Medicines Consortium to reconsider its decision to bar patients with ...

Read more →

Counting the cost of offering better care

Many will have seen the recent news that the first and only targeted chemotherapy drug for secondary breast cancer has ...

Read more →